Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Mar 2026 and May 2026.
- Largest single sale: $3.1M (82,542 shares) of Kiniksa Pharmaceuticals International, plc on Oct 31, 2025. Filing
- Last sale before this period: Aug 6, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | Chief Medical Officer | May 23, 2018 | Sep 3, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 1, 2026, Kiniksa Pharmaceuticals International, plc: 8,328 shares vested; 4,029 shares withheld by the company for taxes. 1 filing: 1
- May 1, 2026, Kiniksa Pharmaceuticals International, plc: sold 58,424 shares for $3.1M, under a disclosed plan; 58,424 shares vested or acquired by exercising options. 1 filing: 1
- Apr 7, 2026, Kiniksa Pharmaceuticals International, plc: 2,497 shares vested; 1,208 shares withheld by the company for taxes. 1 filing: 1
- Apr 1, 2026, Kiniksa Pharmaceuticals International, plc: 5,831 shares vested; 2,821 shares withheld by the company for taxes. 1 filing: 1
- Mar 2, 2026, Kiniksa Pharmaceuticals International, plc: sold 40,000 shares for $1.8M, under a disclosed plan; 40,000 shares vested or acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.